The buy-to-open put/call ratio volume on major exchange-traded funds (ETFs) indicates that Hedge Fun...
Odyssey: In Search of Earnings Growth
06/06/2018 5:00 am EST
PrimeCap Odyssey Growth Fund (POGRX) seeks to provide long-term capital appreciation. The fund invests primarily in U.S.-based stocks, emphasizing those companies with the potential for above average earnings growth, explains John Persinos, editor of Investing Daily's Personal Finance.
The fund casts a wide net that includes all market sectors and market capitalizations, but tends to focus on large-caps. Earnings growth and that’s POGRX’s bailiwick. Earnings growth has come to the fore this year and rescued the bull market, as stirring inflation, a brewing trade war, rising interest rates, geopolitical uncertainty, and other headline risks threaten stocks.
Joel P. Fried, POGRX’s lead manager since October 31, 2004, has given priority to large-cap stocks but he’s not averse to including small- and mid-caps.
In the health sector, Fried pinpoints promising biotech firms that are small enough to afford outsized growth but not so large that they approach stodgier Big Pharma size. He also looks for biotech firms with fast earnings growth projections that are leavened with strong balance sheets.
POGRX’s top holding is Nektar Therapeutics (NKTR), a biotech that develops pharmaceuticals for cancer, auto-immune disease, and chronic pain. Nektar is a research-driven company with a pipeline that’s loaded with promising drug candidates.
The fund’s second largest holding is Abiomed (ABMD) which produces medical devices that assist or replace the pumping function of weakened hearts. It also provides continuum of care to heart failure patients.
Micron Technology (MU), coming in at number four, provides semiconductor systems and is well-positioned in such hot areas as autonomous cars, artificial intelligence, machine-to-machine learning, the Internet of Things, virtual/augmented reality, and the cloud.
Interestingly, fund manager Fried has added two major airline carriers to the portfolio’s top 10 holdings: United Continental Holdings (UAL) at number six and American Airlines Group (AAL) at number seven.
Most investors wouldn’t associate airlines with high earnings growth, but Fried shares the assessment of super investor Warren Buffett that airlines are underappreciated and poised for fast growth.
The average analyst expectation is that corporate profits this year will continue to rack up double-digit gains. This upward trajectory of earnings growth gives POGRX plenty of room to run.
Related Articles on FUNDS
Dividend Aristocrats are a group of S&P 500 stocks that have boosted their annual dividend payou...
We’ve reached the phase of the economic and investment cycle when income investors need to thr...
Ignore the doomsayers: 2019 is setting up to be a strong year for equities—and a great year fo...